Marc Pelletier
Overview
Explore the profile of Marc Pelletier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Travis N, King B, Fernandez A, Hassanabad A, Fedak P, et al.
CJC Open
. 2025 Mar;
7(2):193-202.
PMID: 40060216
The pericardial space provides a homeostatic environment that facilitates optimal cardiac function. The pericardial space contains pericardial fluid (PCF) and other tissue sources, including pericardial adipose tissue and the great...
2.
Hungate J, Onders R, El Diasty M, Abu-Omar Y, Arora R, Baeza C, et al.
JTCVS Open
. 2025 Jan;
22():76-84.
PMID: 39780786
Objective: Prolonged mechanical ventilation after cardiac surgery significantly increases morbidity and mortality. The aim of this study is to establish the role of diaphragmatic pacing to decrease mechanical ventilation burden...
3.
Kuchibhatla A, Soghrati N, Saleh Y, Rushing G, Halim M, Pelletier M, et al.
J Invasive Cardiol
. 2024 Oct;
37(3).
PMID: 39453868
No abstract available.
4.
Shah A, Ding Y, Walji D, Rabinovich G, Pelletier M, El-Diasty M
Biomarkers
. 2024 Oct;
29(7):485-493.
PMID: 39422445
Objective: To review the utility of galectin-3 (Gal-3) as a biomarker for postoperative adverse outcomes in patients undergoing cardiac surgery. Method: This review was conducted in compliance with the Preferred...
5.
Feroze R, Kang P, Dallan L, Akula N, Galo J, Yoon S, et al.
Catheter Cardiovasc Interv
. 2024 Jul;
104(5):1119-1128.
PMID: 38952304
Background: Transcatheter aortic valve replacement (TAVR) has become an established method of aortic stenosis treatment but suffers from the risk of heart block and pacemaker requirement. Risk stratification for patients...
6.
Hassanabad A, El-Sherbini A, Cherif I, Ahmad B, Gonzalez A, Pelletier M, et al.
Clin Chim Acta
. 2024 May;
559:119722.
PMID: 38734224
Background And Objective: Pericardial Fluid (PF) is a rich reservoir of biologically active factors. Due to its proximity to the heart, the biochemical structure of PF may reflect the pathological...
7.
Bauer T, Santoro A, Lin C, Garrido-Laguna I, Joerger M, Greil R, et al.
J Immunother Cancer
. 2023 Nov;
11(11).
PMID: 38030303
Background: NIS793 is a human IgG2 monoclonal antibody that binds to transforming growth factor beta (TGF-β). This first-in-human study investigated NIS793 plus spartalizumab treatment in patients with advanced solid tumors....
8.
Meric-Bernstam F, Sweis R, Hodi F, Messersmith W, Andtbacka R, Ingham M, et al.
Clin Cancer Res
. 2023 Jun;
29(12):2336.
PMID: 37309603
No abstract available.
9.
Qiang L, Hoffman M, Ali L, Castillo J, Kageler L, Temesgen A, et al.
Gastroenterology
. 2023 Jun;
165(4):874-890.e10.
PMID: 37263309
Background & Aims: Transforming growth factor-b (TGFb) plays pleiotropic roles in pancreatic cancer, including promoting metastasis, attenuating CD8 T-cell activation, and enhancing myofibroblast differentiation and deposition of extracellular matrix. However,...
10.
Ventre K, Roehle K, Bello E, Bhuiyan A, Biary T, Crowley S, et al.
J Immunol
. 2023 Mar;
210(7):991-1003.
PMID: 36881882
Checkpoint blockade immunotherapy has failed in pancreatic cancer and other poorly responsive tumor types in part due to inadequate T cell priming. Naive T cells can receive costimulation not only...